SKIN – The Beauty Health Company
SKIN — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
19.84
Margin Of Safety %
91
Put/Call OI Ratio
0.11
EPS Next Q Diff
0.02
EPS Last/This Y
-0.14
EPS This/Next Y
0.04
Price
0.81
Target Price
1.69
Analyst Recom
3.22
Performance Q
-44.47
Upside
-964.2%
Beta
1.23
Ticker: SKIN
20 items
«
‹
of 1
›
»
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-02-27 | SKIN | 1.05 | 0.21 | 0.00 | 1635 |
| 2026-03-02 | SKIN | 1.1 | 0.22 | 0.00 | 1540 |
| 2026-03-03 | SKIN | 1.09 | 0.19 | 0.14 | 1732 |
| 2026-03-04 | SKIN | 1.105 | 0.19 | 0.00 | 1727 |
| 2026-03-05 | SKIN | 1.12 | 0.19 | 0.00 | 1752 |
| 2026-03-06 | SKIN | 1.15 | 0.18 | 0.00 | 1800 |
| 2026-03-09 | SKIN | 1.175 | 0.18 | 0.75 | 1818 |
| 2026-03-10 | SKIN | 1.135 | 0.21 | 10.48 | 1937 |
| 2026-03-11 | SKIN | 1.13 | 0.33 | 0.00 | 2131 |
| 2026-03-12 | SKIN | 1.07 | 0.32 | 0.05 | 2179 |
| 2026-03-13 | SKIN | 1.06 | 0.32 | 0.10 | 2179 |
| 2026-03-17 | SKIN | 1.17 | 0.16 | 0.00 | 4470 |
| 2026-03-18 | SKIN | 1.18 | 0.16 | 0.00 | 4463 |
| 2026-03-19 | SKIN | 1.165 | 0.16 | 0.01 | 4392 |
| 2026-03-20 | SKIN | 1.115 | 0.17 | 0.00 | 4240 |
| 2026-03-23 | SKIN | 1.155 | 0.11 | 0.00 | 3295 |
| 2026-03-24 | SKIN | 1.105 | 0.11 | 0.00 | 3295 |
| 2026-03-25 | SKIN | 1 | 0.11 | 999.99 | 3312 |
| 2026-03-26 | SKIN | 0.8985 | 0.11 | 0.00 | 3322 |
| 2026-03-27 | SKIN | 0.8028 | 0.11 | 0.50 | 3319 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
20 items
«
‹
Current Page1 of 1
›
»
20 items
«
‹
of 1
›
»
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-02-27 | SKIN | 1.05 | - | - | 0.16 |
| 2026-03-02 | SKIN | 1.10 | - | - | 0.16 |
| 2026-03-03 | SKIN | 1.09 | - | - | 0.16 |
| 2026-03-04 | SKIN | 1.10 | - | - | 0.16 |
| 2026-03-05 | SKIN | 1.12 | - | - | 0.16 |
| 2026-03-06 | SKIN | 1.14 | - | - | 0.16 |
| 2026-03-09 | SKIN | 1.17 | - | - | 0.16 |
| 2026-03-10 | SKIN | 1.13 | - | - | 0.16 |
| 2026-03-11 | SKIN | 1.12 | - | - | 0.16 |
| 2026-03-12 | SKIN | 1.07 | - | - | 0.16 |
| 2026-03-13 | SKIN | 1.28 | - | - | 0.16 |
| 2026-03-17 | SKIN | 1.17 | - | - | 0.16 |
| 2026-03-18 | SKIN | 1.18 | - | - | 0.16 |
| 2026-03-19 | SKIN | 1.16 | - | - | 0.16 |
| 2026-03-20 | SKIN | 1.12 | -125.0 | - | 0.12 |
| 2026-03-23 | SKIN | 1.15 | - | - | -0.22 |
| 2026-03-24 | SKIN | 1.11 | - | - | -0.22 |
| 2026-03-25 | SKIN | 1.00 | - | - | -0.22 |
| 2026-03-26 | SKIN | 0.90 | - | - | -0.22 |
| 2026-03-27 | SKIN | 0.81 | - | - | -0.22 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
20 items
«
‹
Current Page1 of 1
›
»
20 items
«
‹
of 1
›
»
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-02-27 | SKIN | 0.00 | -1.52 | 20.36 |
| 2026-03-02 | SKIN | 0.00 | -1.20 | 20.36 |
| 2026-03-03 | SKIN | 0.00 | -1.20 | 20.36 |
| 2026-03-04 | SKIN | 0.00 | -1.20 | 20.36 |
| 2026-03-05 | SKIN | 0.00 | -1.20 | 20.36 |
| 2026-03-06 | SKIN | 0.00 | -1.20 | 20.36 |
| 2026-03-09 | SKIN | 0.00 | -1.20 | 20.36 |
| 2026-03-10 | SKIN | 0.00 | -1.20 | 20.36 |
| 2026-03-11 | SKIN | 0.00 | -1.20 | 20.28 |
| 2026-03-12 | SKIN | 0.00 | -1.20 | 20.28 |
| 2026-03-13 | SKIN | 0.00 | -1.20 | 20.28 |
| 2026-03-17 | SKIN | 0.00 | -1.19 | 20.24 |
| 2026-03-18 | SKIN | 0.00 | -1.19 | 20.24 |
| 2026-03-19 | SKIN | 0.00 | -1.19 | 20.24 |
| 2026-03-20 | SKIN | 0.00 | -1.19 | 20.24 |
| 2026-03-23 | SKIN | 0.00 | -1.19 | 20.24 |
| 2026-03-24 | SKIN | 0.00 | -1.19 | 20.24 |
| 2026-03-25 | SKIN | 0.00 | -1.19 | 19.84 |
| 2026-03-26 | SKIN | 0.00 | -1.19 | 19.84 |
| 2026-03-27 | SKIN | 0.00 | -1.19 | 19.84 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
20 items
«
‹
Current Page1 of 1
›
»
Last Quarter Act. EPS
-0.06
Avg. EPS Est. Current Quarter
-0.09
Avg. EPS Est. Next Quarter
-0.04
Insider Transactions
Institutional Transactions
-1.19
Beta
1.23
Average Sales Estimate Current Quarter
66
Average Sales Estimate Next Quarter
76
Fair Value
1.54
Quality Score
49
Growth Score
40
Sentiment Score
2
Actual DrawDown %
97.3
Max Drawdown 5-Year %
Target Price
1.69
P/E
Forward P/E
PEG
P/S
0.34
P/B
1.68
P/Free Cash Flow
2.77
EPS
-0.2
Average EPS Est. Cur. Y
-0.22
EPS Next Y. (Est.)
-0.18
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-3.16
Relative Volume
1.56
Return on Equity vs Sector %
-40.1
Return on Equity vs Industry %
-42
EPS 1 7Days Diff
-0.1
EPS 1 30Days Diff
-0.09
EBIT Estimation
◆
SKIN
Consumer Defensive
$0.81
📉
N/A
Swing / Pullback
Buy the dip on strong trends
WEAK
Trend
20/20
Pullback
5/25
Volume
3/15
Valuation
15/20
TP/AR
0/10
Options
8/10
RSI
29.1
Range 1M
3.8%
🚀
N/A
Momentum Growth
Ride accelerating trends
WEAK
Momentum
18/25
Growth
11/30
Estimates
2/20
Inst/Vol
3/15
Options
8/10
EPS Yr
-113.9%
EPS NY
31.3%
52W%
2.1%
💎
N/A
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+97.5% upside
Quality
6/30
Valuation
23/30
Growth
11/25
Stability
3/10
LT Trend
4/5
Upside
+97.5%
Quality
49
MoS
91%
Click a card to see score breakdown
Full Analysis →
Sector: Consumer Defensive
Industry: Household & Personal Products
Employees: 613
The Beauty Health Company, a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions in the Americas, the Asia-Pacific, Europe, the Middle East, Africa, Canada, and Latin America. The company's flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling and nanoneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive peptide solutions and take home sprays for treating scalp health. In addition, it operates the MyBeautyHealth mobile application for consumers to earn loyalty points and unlock savings, log skin concerns and receive personalized treatment plans, and find and connect with Hydrafacial providers, as well as offers boosters. The Beauty Health Company was founded in 1997 and is headquartered in Long Beach, California.
SKIN
Latest News
—
Caricamento notizie per SKIN…
stock quote shares SKIN – The Beauty Health Company Stock Price stock today
news today SKIN – The Beauty Health Company stock forecast ,stock prediction 2023 2024 2025
marketwatch SKIN – The Beauty Health Company yahoo finance google finance
stock history SKIN – The Beauty Health Company invest stock market
stock prices SKIN premarket after hours
ticker SKIN fair value insiders trading